| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966374 | Vaccine | 2013 | 7 Pages |
Abstract
Our findings show that Hep-c can not only preserve the alum capacity to effectively stimulate production of the antibodies but also cover its inefficiency in inducing Th1 response and prompting cellular immunity. Thus, by boosting the performance of the hepatitis B vaccine, it seemed that this nano-adjuvant has the suitable potential to be used in the commercial HBS vaccine formulation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Saideh Fakharzadeh, Somayeh Kalanaky, Maryam Hafizi, Mohammad Mahdi Goya, Zahra Masoumi, Said Namaki, Nezhat Shakeri, Maryam Abbasi, Mehdi Mahdavi, Mohammad Hassan Nazaran,